Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

731 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.
Adcock IM, Nasuhara Y, Stevens DA, Barnes PJ. Adcock IM, et al. Br J Pharmacol. 1999 Jun;127(4):1003-11. doi: 10.1038/sj.bjp.0702613. Br J Pharmacol. 1999. PMID: 10433509 Free PMC article.
The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.
Newton R, Cambridge L, Hart LA, Stevens DA, Lindsay MA, Barnes PJ. Newton R, et al. Br J Pharmacol. 2000 Jul;130(6):1353-61. doi: 10.1038/sj.bjp.0703431. Br J Pharmacol. 2000. PMID: 10903976 Free PMC article.
Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells.
Newton R, Hart LA, Stevens DA, Bergmann M, Donnelly LE, Adcock IM, Barnes PJ. Newton R, et al. Eur J Biochem. 1998 May 15;254(1):81-9. doi: 10.1046/j.1432-1327.1998.2540081.x. Eur J Biochem. 1998. PMID: 9652398
Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-kappaB and JNK activation.
Newton R, Stevens DA, Hart LA, Lindsay M, Adcock IM, Barnes PJ. Newton R, et al. FEBS Lett. 1997 Nov 24;418(1-2):135-8. doi: 10.1016/s0014-5793(97)01362-8. FEBS Lett. 1997. PMID: 9414112
Interactions of glucocorticoids and beta 2-agonists.
Adcock IM, Stevens DA, Barnes PJ. Adcock IM, et al. Eur Respir J. 1996 Jan;9(1):160-8. doi: 10.1183/09031936.96.09010160. Eur Respir J. 1996. PMID: 8834349 Review.
Diphenyl diselenide and its interaction with antifungals against Aspergillus spp.
Melo AM, Poester VR, Trapaga M, Nogueira CW, Zeni G, Martinez M, Sass G, Stevens DA, Xavier MO. Melo AM, et al. Among authors: stevens da. Med Mycol. 2020 Aug 25:myaa072. doi: 10.1093/mmy/myaa072. Online ahead of print. Med Mycol. 2020. PMID: 32844203
Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains.
Sass G, Nazik H, Chatterjee P, Stevens DA. Sass G, et al. Among authors: stevens da. Med Mycol. 2020 Aug 22:myaa066. doi: 10.1093/mmy/myaa066. Online ahead of print. Med Mycol. 2020. PMID: 32827431
731 results
Jump to page
Feedback